| 1 |
Bioworld. link to homepage. (2) |
| 2 |
Bioworld |
| 3 |
Genmab banks $750m up front in $3.9b oncology alliance with abbvie |
| 4 |
Bıo digital: covıd-19 vaccines outlook offers reasons for hope, concern |
| 5 |
Public-private partners***ps key to development of new alzheimer’s disease therapies |
| 6 |
Checkmate lands $85m series c to continue tlr9 wars |
| 7 |
Opthea’s opt-302 meets primary endpoints in phase ııa diabetic macular edema trial |
| 8 |
Today's news in brief (2) |
| 9 |
Canbridge moves to expand rare disease pipeline with uma*** collaboration |
| 10 |
Senator: now’s the time to plan for next pandemic |
| 11 |
ındia posts draft rules for compa***ionate use of unapproved drugs |
| 12 |
Astellas reports positive results for roxadustat phase ııı study |
| 13 |
Bioworld medtech |
| 14 |
Gtx medical receives breakthrough device designation for implanted spinal stimulation system |
| 15 |
Beijing export officials using black, whitelists to determine exportability of test kits |
| 16 |
California startup secures $100m for rapid diagnostic platform |
| 17 |
C2i genomics raises $12m series a to bring whole genome pattern recognition to liquid biopsy |
| 18 |
Bioworld medtech’s orthopedics extra for june 10, 2020 |
| 19 |
Cerevasc raises $43.9m to advance hydrocephalus treatment |
| 20 |
Feinstein ınst**utes research demonstrates next step in bioelectronic medicine |
| 21 |
U.s. federal government eyes private sector role in strategic stockpile management |
| 22 |
Johns hopkins cryoablation study could boost procedure to first-line in early kidney cancer |
| 23 |
Bioworld asia |
| 24 |
ınnovent partners with roche in multibillion-dollar deal targeting bispecifics, cell therapies |
| 25 |
Australia’s csl builds out its transplant franchise with acquisition of canadian biotech vitaeris |
| 26 |
Legend leads active day for nasdaq biopharma ıpos |
| 27 |
Asia-focused everest medicines closes $310m series c financing round |
| 28 |
Shanghai startup eccogene bets on small molecules for nash |
| 29 |
Chi-med and beigene partner up to test candidates in combination therapy |
| 30 |
Beigene’s fda-cleared btk inhibitor brukinsa approved in china |
| 31 |
Bıo digital: ındustry looks for collaboration, recognition in covıd-19 efforts |
| 32 |
News in brief |
| 33 |
Csl, university of queensland partner with cepı to bring covıd-19 vaccine to the clinic |